Skip to main content
. 2020 Nov 27;10:598192. doi: 10.3389/fonc.2020.598192

Figure 2.

Figure 2

The clinicopathological and prognostic significances of BTG1 mRNA in colorectal cancer. TCGA database showed that BTG1 was lower expressed in well-, moderately, and poorly differentiated (non-MUC) than in mucinous (MUC) adenocarcinomas (A, P < 0.05). BTG1 expression was positively correlated with K-ras and BRAF mutation of colorectal cancers (A, P < 0.05). BTG1 expression was negatively related to overall survival rate of the patients with colorectal cancer (B, P < 0.05). The prognostic significance of BTG1 mRNA expression was also analyzed using Kaplan–Meier plotter database (C). HR, hazard ratio.